Complement activation induces excessive T cell cytotoxicity in severe COVID-19

被引：0

作者：

Georg, Philipp ^{[1
,2
,3
]}

Astaburuaga-Garcia, Rosario ^{[4
,5
]}

Bonaguro, Lorenzo ^{[6
,7
]}

Brumhard, Sophia ^{[1
,2
,3
]}

Michalick, Laura ^{[8
]}

Lippert, Lena J. ^{[1
,2
,3
]}

Kostevc, Tomislav ^{[9
]}

Gaebel, Christiane ^{[9
]}

Schneider, Maria ^{[9
]}

Streitz, Mathias ^{[9
]}

Demichev, Vadim ^{[10
,11
,12
]}

Gemuend, Ioanna ^{[6
,13
,14
]}

Barone, Matthias ^{[9
]}

Tober-Lau, Pinkus ^{[1
,2
,3
]}

Helbig, Elisa T. ^{[1
,2
,3
]}

Hillus, David ^{[1
,2
,3
]}

Petrov, Lev ^{[9
]}

Stein, Julia ^{[9
]}

Dey, Hannah-Philine ^{[9
]}

Paclik, Daniela ^{[9
]}

Iwert, Christina ^{[9
]}

Muelleder, Michael ^{[15
]}

Aulakh, Simran Kaur ^{[10
]}

Djudjaj, Sonja ^{[16
]}

Buelow, Roman D. ^{[16
]}

Mei, Henrik E. ^{[17
]}

Schulz, Axel R. ^{[17
]}

Thiel, Andreas ^{[2
,3
,18
,19
,20
]}

Hippenstiel, Stefan ^{[1
,2
,3
]}

Saliba, Antoine-Emmanuel ^{[21
]}

Eils, Roland ^{[22
,23
]}

Lehmann, Irina ^{[22
,23
]}

Mall, Marcus A. ^{[23
,24
,25
]}

Stricker, Sebastian ^{[24
]}

Roehmel, Jobst ^{[24
]}

Corman, Victor M. ^{[26
]}

Beule, Dieter ^{[27
]}

Wyler, Emanuel ^{[28
]}

Landthaler, Markus ^{[5
,28
]}

Obermayer, Benedikt ^{[27
]}

von Stillfried, Saskia ^{[16
]}

Boor, Peter ^{[16
,29
,30
]}

Demir, Munevver ^{[31
]}

Wesselmann, Hans ^{[1
,2
,3
]}

Suttorp, Norbert ^{[1
,2
,3
,32
]}

Uhrig, Alexander ^{[1
,2
,3
]}

Mueller-Redetzky, Holger ^{[1
,2
,3
]}

Nattermann, Jacob ^{[33
]}

Kuebler, Wolfgang M. ^{[8
]}

Meisel, Christian ^{[9
,34
]}

机构：

[1] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany

[2] Free Univ Berlin, Berlin, Germany

[3] Humboldt Univ, Berlin, Germany

[4] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany

[5] Humboldt Univ, IRI Life Sci, Berlin, Germany

[6] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany

[7] Deutsch Zentrum Neurodegenerativen Erkrankungen D, Syst Med, Bonn, Germany

[8] Charite Univ Med Berlin, Inst Physiol, Berlin, Germany

[9] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany

[10] Francis Crick Inst, Mol Biol Metab Lab, London, England

[11] Charite Univ Med Berlin, Dept Biochem, Berlin, Germany

[12] Univ Cambridge, Cambridge Ctr Prote, Dept Biochem, Cambridge, England

[13] Univ Bonn, PRECISE Platform Genom & Epigen, DZNE, Bonn, Germany

[14] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia

[15] Charite Univ Med Berlin, High Throughput Mass Spectrometry, Core Facil, Berlin, Germany

[16] Rhein Westfal TH Aachen, Inst Pathol, Univ Clin Aachen, Aachen, Germany

[17] DRFZ Berlin, Mass Cytometry Lab, Berlin, Germany

[18] Tech Univ Berlin, Si M Simulierte Mensch Sci Framework, Berlin, Germany

[19] Charite Univ Med Berlin, Berlin, Germany

[20] Berlin Inst Hlth, Berlin, Germany

[21] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany

[22] Charite Univ Med Berlin, Berlin Inst Hlth BIH, Ctr Digital Hlth, Berlin, Germany

[23] German Ctr Lung Res DZL, Berlin, Germany

[24] Charite Univ Med Berlin, Dept Pediat Resp Med Immunol & Crit Care Med, Berlin, Germany

[25] Charite Univ Med Berlin, Berlin Inst Hlth BIH, Berlin, Germany

[26] Charite Univ Med Berlin, Inst Virol, Berlin, Germany

[27] Charite Univ Med Berlin, Core Unit Bioinformat, Berlin Inst Hlth BIH, Berlin, Germany

[28] Helmholtz Assoc, Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med, Berlin, Germany

[29] Rhein Westfal TH Aachen, Dept Nephrol, Univ Clin Aachen, Aachen, Germany

[30] Rhein Westfal TH Aachen, Univ Clin Aachen, Electron Microscopy Facil, Aachen, Germany

[31] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany

[32] German Ctr Lung Res DZL, Giessen, Germany

[33] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany

[34] Charite Vivantes, Labor Berlin, Dept Immunol, Berlin, Germany

[35] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis, Dept Internal Med, Nijmegen, Netherlands

[36] Univ Med Ctr Hamburg Eppendorf, Bernhard Nocht Inst Trop Med, Dept Trop Med, Dept Med 1, Hamburg, Germany

来源：

CELL | 2022年 / 185卷 / 03期

基金：

英国惠康基金; 欧洲研究理事会; 英国医学研究理事会;

关键词：

R PACKAGE; NK CELLS; REVEALS; EXPRESSION; INFERENCE; INNATE;

D O I：

10.1016/j.cel.2021.12.040

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Severe COVID-19 is linked to both dysfunctional immune response and unrestrained immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, we combined single-cell transcriptomics and single-cell proteomics with mechanistic studies to assess pathogenic T cell functions and inducing signals. We identified highly activated CD16(+) T cells with increased cytotoxic functions in severe COVID-19. CD16 expression enabled immune-complex-mediated, T cell receptor-independent degranulation and cytotoxicity not found in other diseases. CD16(+) T cells from COVID-19 patients promoted microvascular endothelial cell injury and release of neutrophil and monocyte chemoattractants. CD16(+) T cell clones persisted beyond acute disease maintaining their cytotoxic phenotype. Increased generation of C3a in severe COVID-19 induced activated CD16(+) cytotoxic T cells. Proportions of activated CD16(+) T cells and plasma levels of complement proteins upstream of C3a were associated with fatal outcome of COVID-19, supporting a pathological role of exacerbated cytotoxicity and complement activation in COVID-19.

引用

页码：493 / +

页数：46

共 50 条

[41] T cell renaissance in COVID-19
Garner L.
Cifuentes L.
Nature Reviews Immunology, 2020, 20 (9) : 518 - 518
[42] T Cell Metabolism and COVID-19
不详
JOURNAL OF IMMUNOLOGY, 2021, 206 (12): : 2773 - 2773
[43] Is aberrant CD8+T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
Zhang, Chao
Wang, Fu-Sheng
Silvestre, Jean-Sebastien
Arenzana-Seisdedos, Fernando
Tang, Hong
CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (06) : 675 - 676
[44] Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
Chao Zhang
Fu-Sheng Wang
Jean-Sébastien Silvestre
Fernando Arenzana-Seisdedos
Hong Tang
Cellular & Molecular Immunology, 2020, 17 : 675 - 676
[45] Complement cascade in severe forms of COVID-19: Recent advances in therapy
Benmansour, Nassima Chouaki
Carvelli, Julien
Vivier, Eric
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (07) : 1652 - 1659
[46] Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19
Ulrich Hofstadt-van Oy
Slobodan Stankovic
Corinna Kelbel
Daniel Oswald
Simon Larrosa-Lombardi
Thomas Barchfeld
Ulrich Cleff
Journal of Neurology, 2021, 268 : 3125 - 3128
[47] Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome
Raghunandan, Sharmila
Josephson, Cassandra D.
Verkerke, Hans
Linam, W. Matthew
Ingram, Treva C.
Zerra, Patricia E.
Arthur, Connie M.
Stowell, Sean R.
Briones, Michael
Chonat, Satheesh
FRONTIERS IN PEDIATRICS, 2020, 8
[48] Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19
Hofstadt-van Oy, Ulrich
Stankovic, Slobodan
Kelbel, Corinna
Oswald, Daniel
Larrosa-Lombardi, Simon
Barchfeld, Thomas
Cleff, Ulrich
JOURNAL OF NEUROLOGY, 2021, 268 (09) : 3125 - 3128
[49] A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis
Showers, Christopher R.
Nuovo, Gerard J.
Lakhanpal, Amit
Siegel, Caroline H.
Aizer, Juliet
Elreda, Lauren
Halevi, Alexandra
Lai, Andrew R.
Erkan, Doruk
Magro, Cynthia M.
PATHOBIOLOGY, 2021, 88 (01) : 28 - 36
[50] Complement is primarily activated in the lung in a mouse model of severe COVID-19
Szachowicz, Peter J.
Wohlford-Lenane, Christine
Donelson, Cobey J.
Ghimire, Shreya
Thurman, Andrew
Xue, Biyun
Boly, Timothy J.
Verma, Abhishek
Masinovic, Leila
Bermick, Jennifer R.
Rehman, Tayyab
Perlman, Stanley
Meyerholz, David K.
Pezzulo, Alejandro A.
Zhang, Yuzhou
Smith, Richard J. H.
McCray, Paul B.
ISCIENCE, 2025, 28 (03)

← 1 2 3 4 5 →